Marea reports positive Phase I results for MAR002 trial in acromegaly

Single-ascending doses of MAR002 showed a favourable tolerability and safety profile with no drug-related safety signals ...
Vietnam Investment Reviev

T MAXIMUM CAR T therapy clears FDA for phase II trial

The regulator has approved the investigational new drug application to test the therapy for a aggressive brain cancer. BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that ...
Hosted on MSN

T Maximum CAR T therapy clears FDA for phase II trial

BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug ...
BioSpace

T-MAXIMUM Pharmaceutical’s Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma

BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug ...
times.abema

Jinshi's "Dark Turn" from Jealousy!? The Handsome Eunuch Watching Over Maomao Was Too Horror-Like in the Anime "The Apothecary Diaries"

A pitch-black negative aura emanating from the handsome eunuch Jinshi (CV: Takeo Otsuka) due to overwhelming jealousy...! In the anime "The Apothecary Diaries," Jinshi watching Maomao (CV: Aoi Yuuki) ...
MarketWatch

T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma

The MarketWatch News Department was not involved in the creation of this content. BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, ...